BETHESDA, Md. (AP) — BETHESDA, Md. (AP) — Northwest Biotherapeutics Inc. (NWBO) on Wednesday reported a loss of $14.4 million in its second quarter. On a per-share basis, the Bethesda, Maryland-based company said it had a loss of 1 cent. The cancer drug developer posted revenue of $201,000 in the…Read More
Northwest Biotherapeutics Q2 Earnings Snapshot Federal News Network
